Form preview

Get the free NDA 22-272 OxyContin (Oxycodone Hydrochloride Controlled-Release) - accessdata fda

Get Form
This document serves as a review of the labeling revisions submitted by Purdue Pharma for the reformulated OxyContin product, focusing on compliance with health and safety regulations and addressing
We are not affiliated with any brand or entity on this form

Get, Create, Make and Sign nda 22-272 oxycontin oxycodone

Edit
Edit your nda 22-272 oxycontin oxycodone form online
Type text, complete fillable fields, insert images, highlight or blackout data for discretion, add comments, and more.
Add
Add your legally-binding signature
Draw or type your signature, upload a signature image, or capture it with your digital camera.
Share
Share your form instantly
Email, fax, or share your nda 22-272 oxycontin oxycodone form via URL. You can also download, print, or export forms to your preferred cloud storage service.

Editing nda 22-272 oxycontin oxycodone online

9.5
Ease of Setup
pdfFiller User Ratings on G2
9.0
Ease of Use
pdfFiller User Ratings on G2
Here are the steps you need to follow to get started with our professional PDF editor:
1
Log in to account. Start Free Trial and sign up a profile if you don't have one yet.
2
Prepare a file. Use the Add New button. Then upload your file to the system from your device, importing it from internal mail, the cloud, or by adding its URL.
3
Edit nda 22-272 oxycontin oxycodone. Rearrange and rotate pages, add new and changed texts, add new objects, and use other useful tools. When you're done, click Done. You can use the Documents tab to merge, split, lock, or unlock your files.
4
Save your file. Select it from your records list. Then, click the right toolbar and select one of the various exporting options: save in numerous formats, download as PDF, email, or cloud.
With pdfFiller, it's always easy to work with documents. Check it out!

Uncompromising security for your PDF editing and eSignature needs

Your private information is safe with pdfFiller. We employ end-to-end encryption, secure cloud storage, and advanced access control to protect your documents and maintain regulatory compliance.
GDPR
AICPA SOC 2
PCI
HIPAA
CCPA
FDA

How to fill out nda 22-272 oxycontin oxycodone

Illustration

How to fill out NDA 22-272 OxyContin (Oxycodone Hydrochloride Controlled-Release)

01
Download NDA 22-272 OxyContin (Oxycodone Hydrochloride Controlled-Release) from the FDA website.
02
Read the instructions provided with the NDA carefully.
03
Fill out the initial sections, including sponsor information and drug details.
04
Provide clinical and non-clinical data that supports the drug's safety and efficacy.
05
Include proposed labeling information and packaging details.
06
Attach any relevant studies and data to support the application.
07
Review the entire document for completeness and accuracy.
08
Submit the NDA to the FDA electronically through the appropriate submission portal.

Who needs NDA 22-272 OxyContin (Oxycodone Hydrochloride Controlled-Release)?

01
Pharmaceutical companies looking to market OxyContin.
02
Healthcare providers involved in prescribing controlled-release Oxycodone.
03
Patients seeking information on the availability of OxyContin.
04
Regulatory bodies monitoring the approval of controlled substances.
Fill form : Try Risk Free
Users Most Likely To Recommend - Summer 2025
Grid Leader in Small-Business - Summer 2025
High Performer - Summer 2025
Regional Leader - Summer 2025
Easiest To Do Business With - Summer 2025
Best Meets Requirements- Summer 2025
Rate the form
4.0
Satisfied
22 Votes

People Also Ask about

Description. Oxycodone is used to relieve pain severe enough to require opioid treatment and when other pain medicines did not work well enough or cannot be tolerated. It belongs to the group of medicines called opioid analgesics (pain medicines). Oxycodone acts on the central nervous system (CNS) to relieve pain.
One key difference is that oxycodone is more potent than hydrocodone. This means that it takes less oxycodone to produce the same effects as hydrocodone. Oxycodone is also more likely to be abused than hydrocodone because it produces stronger effects. This also means that oxycodone has a higher risk of overdose.
The generic name for Percocet is oxycodone acetaminophen.
Percocet is a combination medication that includes both oxycodone and acetaminophen. The addition of acetaminophen enhances the pain-relieving effects of oxycodone. This combination makes Percocet effective for treating moderate to severe pain, often used for short-term pain management.
Common brands of oxycodone include Endone, OxyContin and OxyNorm.
Both Percocet and oxycodone-CR products relieve pain, but while Percocet gives relief for about five hours, the effects of oxycodone-CR last for about 12 hours, when taken as prescribed. Percocet contains five milligrams of oxycodone, which is all released when the pill is taken.
Oxycodone HCl Controlled-Release Tablets are designed to provide controlled delivery of oxycodone over 12 hours. Breaking, chewing or crushing Oxycodone HCl Controlled-Release Tablets eliminates the controlled delivery mechanism and results in the rapid release and absorption of a potentially fatal dose of oxycodone.
OxyContin, a trade name for the narcotic oxycodone hydrochloride, is a painkiller available in the United States only by prescription. OxyContin is legitimately prescribed for relief of moderate to severe pain resulting from injuries, bursitis, neuralgia, arthritis, and cancer.
OxyContin, a trade name for the narcotic oxycodone hydrochloride, is a painkiller available in the United States only by prescription.
The differences are simply that oxycodone is an opioid substance that is the main ingredient in a number of pain medications (including OxyContin) and that OxyContin is the time-release version of oxycodone.

For pdfFiller’s FAQs

Below is a list of the most common customer questions. If you can’t find an answer to your question, please don’t hesitate to reach out to us.

NDA 22-272 refers to the New Drug Application submitted for OxyContin, which contains Oxycodone Hydrochloride in a controlled-release formulation. It is used for the management of pain severe enough to require an opioid analgesic.
The manufacturer or sponsor of the drug is required to file NDA 22-272 for OxyContin. This includes pharmaceutical companies that seek approval for new drugs from the FDA.
To fill out NDA 22-272, the applicant must submit detailed information including clinical study data, manufacturing processes, labeling, and proposed usage. The application must comply with FDA guidelines and include evidence of safety and efficacy.
The purpose of NDA 22-272 is to gain FDA approval for OxyContin as a safe and effective medication for patients suffering from severe pain, ensuring community health through regulated medicinal use.
The NDA must include information on the drug's pharmacokinetics, pharmacodynamics, clinical trial results, proposed labeling, manufacturing details, and risk assessments, along with any relevant safety data.
Fill out your nda 22-272 oxycontin oxycodone online with pdfFiller!

pdfFiller is an end-to-end solution for managing, creating, and editing documents and forms in the cloud. Save time and hassle by preparing your tax forms online.

Get started now
Form preview
If you believe that this page should be taken down, please follow our DMCA take down process here .
This form may include fields for payment information. Data entered in these fields is not covered by PCI DSS compliance.